AstraZeneca Pharma India has surged 18% to Rs 871 after reporting net profit of Rs 1.77 crore for the quarter ended June 30, 2013 (Q1) on back of higher revenues.The pharmaceutical company had loss of Rs 8.15 crore in year ago quarter and Rs 18.57 crore in preceding quarter.
Revenues from operations for the quarter grew by 37% at Rs 125 crore against Rs 91 crore in the corresponding quarter of previous year, AstraZeneca Pharma India said in a statement.
The stock opened at Rs 760 and hit a high of Rs 878 on BSE. A combined 296,035 shares changed hands on the counter till 1020 hours against an average sub 100,000 shares that were traded daily in past two weeks.
Revenues from operations for the quarter grew by 37% at Rs 125 crore against Rs 91 crore in the corresponding quarter of previous year, AstraZeneca Pharma India said in a statement.
The stock opened at Rs 760 and hit a high of Rs 878 on BSE. A combined 296,035 shares changed hands on the counter till 1020 hours against an average sub 100,000 shares that were traded daily in past two weeks.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%